TUMOR DIAGNOSTICS

CancerAdvice

Synthesizes the tumor profile, treatment history, current disease status, approved and off-label options, and relevant clinical trials into a personalized strategy.

STARTING MATERIAL

No new specimen may be required if a suitable tumor report exists. Provide molecular and pathology reports, diagnosis and metastatic sites, histology, ECOG, comorbidities, treatment history, progression/imaging, tumor markers, and planned procedures.

METHOD / ANALYTICAL SCOPE

Expert evidence review integrating molecular findings, prior therapy, current clinical status, in-label/off-label options, and clinical-trial opportunities.

MEDICAL REPORT

Summary of the tumor profile and history, prioritized treatment strategy, evidence appraisal, and potentially relevant trials; documentation may support payer discussion.

TURNAROUND

Confirmed after completeness review of the molecular and clinical documentation.

CLINICAL VALUE

Where this test is strongest

Connects variants to the patient's actual treatment history

Includes in-label, off-label, and trial options

Can follow CancerPrecision, CancerNeo, CancerEssential, or CancerDetect

Structured rationale for tumor-board discussion

LIMITATIONS

What must remain visible

!This is not a sequencing assay and has no fixed gene list.

!The treating oncology team makes the final treatment decision.

!Recommendations depend on complete, current clinical records and changing evidence.

GENE & ANALYTICAL SCOPE

Interpretation service

No gene list: CancerAdvice interprets an existing molecular profile in the full clinical context.

Clinical evidence synthesisCase-specific analytical scope
+

Molecular findings, pathology, performance status, comorbidities, prior therapy, progression, imaging, markers, planned procedures, approved treatments, off-label evidence, and clinical trials.

No fixed gene-by-gene list applies to this scope.

BEFORE ORDERING

Confirm the current laboratory specification.

The official case review and quotation confirm eligibility, accepted material, validated coverage and variant classes, consent, turnaround, price, and report pathway.

Prepare case enquiry
WhatsApp